About Rivaroxaban
Class: | Anticoagulant, Direct Factor Xa Inhibitor
Use: | Prevention of venous thromboembolism (VTE) in patients undergoing hip or knee replacement surgery; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); reduction of the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; and prevention of recurrent DVT and PE.
Adult dose: | 2.5 mg taken orally twice daily after at least 6 months of treatment for DVT/PE; for nonvalvular atrial fibrilla
Drug Class
Anticoagulant, Direct Factor Xa Inhibitor
Uses & Indications
Prevention of venous thromboembolism (VTE) in patients undergoing hip or knee replacement surgery; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); reduction of the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; and prevention of recurrent DVT and PE.
Storage Requirements
Store at room temperature (20-25°C or 68-77°F) in a tightly closed container; protect from moisture.
Manufacturer & Packaging
Manufacturer: Bayer Pharma AG, GERMANY
Package Size
56's (14's Blister x 4)
Price & Supplier
Price in UAE: AED 315.50
Dosage Information
Adult Dose
2.5 mg taken orally twice daily after at least 6 months of treatment for DVT/PE; for nonvalvular atrial fibrillation, the dose is typically 20 mg once daily (with adjustments based on renal function).
Pediatric Dose
Safety and efficacy not established in pediatric patients; not recommended for use in children.
Side Effects
Common side effects include bleeding complications (e.g., gastrointestinal bleeding, hematoma), nausea, headache, dizziness, and elevated liver enzymes.
Contraindications & Precautions
Active bleeding, severe hypersensitivity to rivaroxaban, severe renal impairment (CrCl < 15 mL/min), and concomitant use of strong dual inhibitors of CYP3A4 and P-glycoprotein.
Important Warnings
Increased risk of bleeding; monitor for signs and symptoms of bleeding; use caution in patients with renal impairment, hepatic impairment, or those undergoing invasive procedures. Discontinue prior to surgery as advised.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.